I think they're being cautious. A lot of water has to flow under the bridge to get to that magical 100000 oz/annum. Also don't forget they have to invest a fair amount of capital at sweeden and jokisivu in the order of 10 mill (total) to get them fully operational. Then take out a few mill for exploration and the free cash is down to 22 - 23 mill. Divide by 760 and esp is around 2.8 - 3c. Using a multiple of 7 (usual for miners) and I get a valuation of 19 - 21c. Bear in mind that this gives no valuation to eritrea or northern finland.
Because Chalice is now aggressively going to push forward a valuation of at least 2c is warranted for that asset. So I'm now at 21 - 23.
If they get a JV partner for Hanhimaa then they can look to put a value on it, but too early yet.
As for their other non-producing assets K and K are together worth about 1.5 - 2c.
Therefore I get a valuation of 22 - 25c. That's based on 80000oz. Now if they get a partner for Hanhimaa then I could stretch it to 24 - 26c but not before. IMO. The companies own valuation came in at 18c. But they are as proven ultra conservative.
Note, to get the valuation of non producing assets I gave a valuation of $60 - 65 per oz
heers
- Forums
- ASX - By Stock
- DRA
- presentation
presentation, page-9
Featured News
Add DRA (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.00 |
Change
0.000(0.00%) |
Mkt cap ! $110.9M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11771 | $1.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.00 | 72 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11771 | 1.955 |
1 | 5141 | 1.950 |
1 | 10000 | 1.805 |
1 | 550 | 1.800 |
1 | 715 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
2.000 | 72 | 1 |
2.020 | 507 | 1 |
2.030 | 5528 | 2 |
2.040 | 43390 | 2 |
2.050 | 4908 | 2 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
DRA (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online